AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,069,000 | -32.4% | 25,623 | -14.4% | 0.00% | -50.0% |
| Q3 2016 | $1,581,000 | +62.8% | 29,935 | +29.2% | 0.00% | +100.0% |
| Q2 2016 | $971,000 | +142.8% | 23,176 | +135.2% | 0.00% | 0.0% |
| Q1 2016 | $400,000 | -51.0% | 9,853 | -21.6% | 0.00% | 0.0% |
| Q4 2015 | $816,000 | -7.4% | 12,567 | +0.6% | 0.00% | 0.0% |
| Q3 2015 | $881,000 | -44.8% | 12,487 | -13.1% | 0.00% | -50.0% |
| Q2 2015 | $1,597,000 | -73.4% | 14,368 | -77.4% | 0.00% | -75.0% |
| Q1 2015 | $6,008,000 | -14.5% | 63,716 | +1.6% | 0.01% | -11.1% |
| Q4 2014 | $7,026,000 | +108.4% | 62,710 | +14.1% | 0.01% | +80.0% |
| Q3 2014 | $3,371,000 | +60.9% | 54,939 | +20.2% | 0.01% | +66.7% |
| Q2 2014 | $2,095,000 | +171.4% | 45,714 | +131.8% | 0.00% | +200.0% |
| Q1 2014 | $772,000 | +70.8% | 19,718 | +4.6% | 0.00% | 0.0% |
| Q4 2013 | $452,000 | -14.9% | 18,858 | -0.6% | 0.00% | 0.0% |
| Q3 2013 | $531,000 | – | 18,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 514,711 | $22,194,338 | 5.19% |
| ACUTA CAPITAL PARTNERS, LLC | 78,700 | $3,393,544 | 2.86% |
| Bellevue Group AG | 3,879,548 | $167,286,110 | 2.72% |
| Parkman Healthcare Partners LLC | 446,416 | $19,249,458 | 2.58% |
| Eagle Health Investments LP | 330,830 | $14,265,390 | 2.50% |
| SECTOR GAMMA AS | 121,844 | $5,253,913 | 1.96% |
| Frazier Life Sciences Management, L.P. | 871,974 | $37,599,519 | 1.76% |
| BVF INC/IL | 1,190,107 | $51,317,414 | 1.44% |
| Rock Springs Capital Management LP | 1,044,261 | $45,028,534 | 1.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,654,502 | $243,822,126 | 1.15% |